🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchMonthly semaglutide depot formulation — my results so far Page 7

Monthly semaglutide depot formulation — my results so far

tony_orlando Mon, Jul 22, 2024 at 3:23 PM 39 replies 2,686 viewsPage 7 of 8
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Aug 27, 2024 at 6:41 PM#31
SleepDoc_PDX said:
One habit that pays for itself: post the method alongside the number.

Genuinely useful, thank you. I had the facts and not the framework.

29 2josh_phd_bmore, roxy_nash, tony_orlando and 26 others
Reply Quote Save Share Report
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Aug 30, 2024 at 12:51 PM#32

Adding the clinical framing, because it changes how the question reads. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

30 3KarenAZ_mom, zoe_NC, Dr.ObesityLA and 27 others
Reply Quote Save Share Report
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Sep 2, 2024 at 6:59 AM#33
Dr.ObesityLA said:
Worth answering the question that was asked rather than the one behind it.

Same pattern here, and in the same order.

31 4sean_dublin, hannah_MT, Dr.SportsMedIN and 28 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Sep 5, 2024 at 1:05 AM#34
Dr.ObesityLA said:
Worth answering the question that was asked rather than the one behind it.

There is a second half to this that has not been said yet. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

I would rather be corrected than agreed with, if it comes to it.

32 5AussieAnna, BethLabQueen, ChrisMacros and 29 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Sep 7, 2024 at 7:10 PM#35

The figures, for anyone assembling their own picture. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

33 6SaraMom3, Dr.MetabolicMD, RetaRick_CA and 30 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register